| Literature DB >> 20386700 |
Noton K Dutta1, Smriti Mehra, Deepak Kaushal.
Abstract
BACKGROUND: Novel therapeutics are urgently needed to control tuberculosis (TB). Thioridazine (THZ) is a candidate for the therapy of multidrug and extensively drug-resistant TB. METHODOLOGY/PRINCIPALEntities:
Mesh:
Substances:
Year: 2010 PMID: 20386700 PMCID: PMC2851646 DOI: 10.1371/journal.pone.0010069
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Genes induced in all condition tested.
| Condition | Rv number | Gene* | Description | Functional Category | Fold induction (p value) [qRT-PCR] | |||
| 1 h | 2 h | 4 h | 6 h | |||||
| IXMIC up regulation | Rv1057 | Conserved hypothetical | 10 | 3.69(0.01) | 9.79(0.004) | 9.4(0.005) | 1(0.003) | |
| Rv1497 |
| Probable esterase LIPL | 3 | 2.154(0.01) | 3.21(0.01) | 6.4(0.002) | 4(0.008) | |
| Rv2483c |
| Possible transmembrane phospholipid | 1 | 2.292(0.01) | 1.94(0.04) | 3.3(0.0021) | 4.3(0.01) | |
| Rv2710 |
| Sigma Factor B | 2 | 2.449(0.01)[2.11] | 3.98(0.004)[9.27] | 5(0.01) [1.02] | 7(0.01) [1.47] | |
| Rv2711 |
| Iron-dependent repressor and activator ider | 9 | 1.832(0.02) | 1.95(0.03) | 2.3(0.009) | 2.9(0.006) | |
| Rv2744c | Conserved 35 KDA alanine rich protein | 10 | 2.17(0.03) | 2.26(0.03) | 9.1(0.003) | 5.4(0.007) | ||
| Rv2745c | Possible transcriptional regulatory protein | 9 | 2.02(0.04) [1.31] | 3.32(0.01) [5.24] | 35(0.001) [3.27] | 8(0.005) [19.09] | ||
| Rv3065 |
| Multidrug-transport integral membrane protein MMR | 3 | 10.81(0.0009) [4.86] | 1.88(0.001) [2.27] | 23(0.0004)[41.22] | 31(0.0002)[6.04] | |
| Rv3160c | Transcriptional regulatory protein | 9 | 10.95(0.0039) [11.26] | 8.39(0.006) | 19(0.0006) | 39(0.001) | ||
| Rv3161c | Possible dioxygenase | 7 | 76.8(4.70E-05) [41.65] | 15.6(0.008) | 38(1.85E-05) | 74(0.0005) | ||
| 4XMIC up regulation | Rv0251c |
| Hypothetical exported protein | 3 | 10.82(0.0005) [2.93] | 17(0.0009) [3.58] | 29(0.0003) [5.90] | 36(0.04) [7.53] |
| Rv1040c | PE family protein | 6 | 1.983(0.04) | 4.49(2.44E-06) | 2.4(0.007) | 2.3(0.0004) | ||
| Rv1057 | Conserved hypothetical protein | 10 | 9.5(0.003) | 12.7(0.002) | 8.3(0.01) | 7.9(0.003) | ||
| Rv1403c | Putative methyltransferase | 7 | 1.73(0.04) | 6.41(0.002) | 7(0.0004) | 3.8(0.002) | ||
| Rv1404 | Probable transcriptional regulatory protein | 9 | 2.53(0.02) | 2.82(0.01) | 3.7(0.01) | 3.1(0.01) | ||
| Rv1461 | Conserved hypothetical protein | 10 | 2.98(0.01) | 4.98(0.01) | 7.8(0.002) | 5.6(0.003) | ||
| Rv1463 | Probable conserved ATP-binding protein | 3 | 2.92(0.01653) | 4.83(0.004) | 5.4(0.01) | 3.9(0.01) | ||
| 4XMIC up regulation | Rv1466 | Conserved hypothetical protein | 10 | 2.97(0.04) | 3.91(0.01) | 5.7(0.01) | 4.2(0.01) | |
| Rv1497 |
| Probable esterase LIPL | 3 | 5.02(0.01) | 5.59(0.007) | 2.8(0.01) | 2.6(0.01) | |
| Rv1854c |
| Probable NADH dehydrogenase NDH | 7 | 3.94(0.004) | 2.12(0.01) | 3.3(0.01) | 2.1(0.01) | |
| Rv2053c | Probable transmembrane protein | 3 | 10.19(0.001) | 4.32(0.01) | 2(0.0008) | 2.8(0.04) | ||
| Rv2694c | Conserved hypothetical protein | 10 | 3.04(0.01) | 4.69(0.009) | 3.1(0.02) | 3.2(0.004) | ||
| Rv2710 |
| RNA polymerase sigma factor SIGB | 2 | 10.34(0.004) [17.61] | 14.2(0.01) [12.32] | 9.5(0.0006) [10.73] | 5.7(0.0009) [12.60] | |
| Rv2743c | possible conserved transmembrane alanine rich protein | 3 | 3.74(0.01) | 3.3(0.01) | 3(0.02) | 4(0.03) | ||
| Rv2745c | Possible transcriptional regulatory protein | 9 | 5.16(0.01) [3.43] | 5.83(0.02) [11.33] | 146(0.001) [13.27] | 10(0.005) [89.55] | ||
| Rv3065 |
| Multidrugs-transport integral membrane protein MMR | 3 | 24.66(0.001) [15.44] | 24(0.0006) [5.20] | 32(0.01) [26.40] | 59(0.003)[100.60] | |
| Rv3160c | Possible transcriptional regulatory protein | 9 | 66.98(0.001) [26.56] | 31.4(0.0005) | 23(0.0008) | 21(0.0005) | ||
| Rv3161c | Possible dioxygenase | 7 | 237.3(0.01) [155.54] | 28.8(0.02) | 48(0.0003) | 56(0.003) | ||
| Rv3162c | Possible integral membrane protein | 3 | 2 (0.04) | 4.3(0.009) | 2.9(0.04) | 4(0.01) | ||
| 4XMIC down regulation | Rv2950c |
| Probable FATTY-ACID-CoA ligase FADD29 | 1 | −4.39(0.01) | −12.33(0.001) | −3.92(0.008) | −2.30(0.02) |
| Rv0170 |
| MCE-family protein MCE1B | 0 | −7.73(0.003) | −3.15(0.001) | −2.05(0.005) | −2.39(0.003) | |
| Rv2450c |
| Probable resuscitation-promoting factor RPFE | 3 | −1.87(0.001) | −7.19(0.0001) | −3.76(0.001) | −3.55(5.05E-05) | |
| Rv3920c | Hypothetical protein similar to JAG protein | 10 | −1.69(0.009) | −2.77(0.003) | −2.94(0.01) | −3.07(0.002) | ||
Genes are annotated as described by the Pasteur Institute on TubercuList (http://genolist.pasteur.fr/TubercuList).
Enclosed genes found to be induced under both Ix and 4x MIC conditions are in bold.
Values in square brackets represent the fold induction obtained by qRT-PCR.
Figure 1Functional categorization of the global induction (A) or repression (B) in Mtb gene-expression following 1x (top panel in both A and B) or 4x THZ (bottom panel in both A and B) treatment is shown as a series of pie charts.
The first (leftmost) pie corresponds to an expected distribution of the various functional categories into which the Mtb genes are represented based on the total number of genes corresponding to each category. The number of genes from each functional category, whose expression was perturbed in individual THZ treatment experiments, is represented in the subsequent pies. The first functional category (0 = Virulence and detoxification) begins at 12 O Clock in very pie and the subsequent categories are represented in a clock-wise direction.
Figure 2TEM images of unexposed Mtb CDC 1551 control (A) and following incubation for 6 hr (B, C) and 24 hr (D, E) with 1x MIC (B, D)/4x MIC (C, E) THZ respectively.
The arrows and lines highlight areas of noticeable cell wall damage.
Figure 3Thioridazine (THZ) inhibited the growth of Mtb CDC1551 (A), sigH mutant (B), sigE mutant (C) and σB Knock-In (KI) mutant (D) in a dose-dependent manner.
*, p<0.05 **, p<0.01 ***, p<0.001 were considered to indicate 1 (0.1 x MIC), 10 (1 x MIC) and 40 (4 x MIC) µg/ml THZ-treated groups where the OD values differed significantly compared to the untreated control group. The results represent mean ± SD values from three experiments. σB over expression was induced by the addition of acetamide to 0.2%.
Figure 4Changes in redox status of NADH/NAD+ during treatment of Mtb CDC 1551 and σB (KI) mutant with THZ.
The results represent mean ± SD values from three experiments. σB over expression induced by the addition of acetamide to 0.2%.